Related Experiment Video
Updated: Aug 31, 2025
Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
Published on: June 14, 2020
Multisystem inflammatory syndrome following mild COVID-19 in an unvaccinated Tongan adult
Tim Cutfield1, Yousif Saeed2, Amanda Taylor3
1Infectious Diseases and General Medicine Consultant, Department of Infectious Diseases, Middlemore Hospital, Otahuhu, Auckland, New Zealand.
Abstract:
Multisystem inflammatory syndrome in adults (MIS-A), is a rare post-infectious complication of COVID-19. We describe an illustrative case of MIS-A in an otherwise well, SARS-CoV-2 unvaccinated 25-year-old Tongan man who presented to hospital 30 days after mild COVID-19 illness. We highlight the progression of his illness, including treatment in the Intensive Care Unit (ICU) for cardiogenic shock, and detail temporal evolution of clinical, laboratory and radiographic features of his illness. Clinicians should be alert for possible MIS-A in the weeks after a surge in COVID-19 cases.
Insights
Multisystem inflammatory syndrome in adults (MIS-A) is a rare COVID-19 complication. This case highlights MIS-A progression, including cardiogenic shock, emphasizing the need for clinical vigilance post-COVID-19 surges.
Area of Science:
- Infectious Diseases
- Cardiology
- Critical Care Medicine
Background:
- Multisystem inflammatory syndrome in adults (MIS-A) is a rare but serious post-infectious sequela of SARS-CoV-2 infection.
- While typically associated with pediatric populations, MIS-A can affect adults, presenting with diverse and severe clinical manifestations.
Related Concept Videos
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:14Myocarditis III: Medical Management
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
01:21Myocarditis I: Introduction
01:30Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
01:29Pneumonia II: Pathophysiology